Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Semicarbazide-cadmium_therapy> ?p ?o. }
Showing items 1 to 25 of
25
with 100 items per page.
- Semicarbazide-cadmium_therapy abstract "Semicarbazide-cadmium therapy was an experimental cancer therapy that was tested in several clinical trials in the Soviet Union during the 1960s. Semicarbazide is an irreversible inhibitor of semicarbazide-sensitive amine oxidase (SSAO), an enzyme possibly involved in exacerbation of inflammation. Cadmium is a heavy metal and can also induce apoptosis.The first study in humans was an open pilot trial conducted in Russia in 1957-1962. It was also patented in Russia. This method was successfully used for treatment of patients in later stages of lung, intestinal, and brest cancer, melanoma, and some other cancer types. The Experiments were accompanied by organizational problems (conflict of interest).".
- Semicarbazide-cadmium_therapy wikiPageID "19290856".
- Semicarbazide-cadmium_therapy wikiPageRevisionID "595026523".
- Semicarbazide-cadmium_therapy hasPhotoCollection Semicarbazide-cadmium_therapy.
- Semicarbazide-cadmium_therapy subject Category:Cadmium.
- Semicarbazide-cadmium_therapy subject Category:Experimental_cancer_treatments.
- Semicarbazide-cadmium_therapy subject Category:History_of_medicine.
- Semicarbazide-cadmium_therapy type Abstraction100002137.
- Semicarbazide-cadmium_therapy type Act100030358.
- Semicarbazide-cadmium_therapy type Activity100407535.
- Semicarbazide-cadmium_therapy type Care100654885.
- Semicarbazide-cadmium_therapy type Event100029378.
- Semicarbazide-cadmium_therapy type ExperimentalCancerTreatments.
- Semicarbazide-cadmium_therapy type PsychologicalFeature100023100.
- Semicarbazide-cadmium_therapy type Treatment100658082.
- Semicarbazide-cadmium_therapy type Work100575741.
- Semicarbazide-cadmium_therapy type YagoPermanentlyLocatedEntity.
- Semicarbazide-cadmium_therapy comment "Semicarbazide-cadmium therapy was an experimental cancer therapy that was tested in several clinical trials in the Soviet Union during the 1960s. Semicarbazide is an irreversible inhibitor of semicarbazide-sensitive amine oxidase (SSAO), an enzyme possibly involved in exacerbation of inflammation. Cadmium is a heavy metal and can also induce apoptosis.The first study in humans was an open pilot trial conducted in Russia in 1957-1962. It was also patented in Russia.".
- Semicarbazide-cadmium_therapy label "Semicarbazide-cadmium therapy".
- Semicarbazide-cadmium_therapy sameAs m.04lg9jm.
- Semicarbazide-cadmium_therapy sameAs Q7449365.
- Semicarbazide-cadmium_therapy sameAs Q7449365.
- Semicarbazide-cadmium_therapy sameAs Semicarbazide-cadmium_therapy.
- Semicarbazide-cadmium_therapy wasDerivedFrom Semicarbazide-cadmium_therapy?oldid=595026523.
- Semicarbazide-cadmium_therapy isPrimaryTopicOf Semicarbazide-cadmium_therapy.